Showing results (1-10 of 616) with videos related to
Sort By:
Pageof 62
British Journal of Clinical Pharmacology|January 1, 1984
The interaction between H2-receptor antagonists and beta-adrenoceptor blockersE Mutschler, H Spahn, W KirchArchives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1983
Accumulation and adverse effects of metoprolol and propranolol after concurrent administration of cimetidineW Kirch, H Spahn, H Köhler, et al.Klinische Wochenschrift|November 15, 1982
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidineW Kirch, H Spahn, H Köhler, et al.European Journal of Clinical Pharmacology|January 1, 1986
Penbutolol Pharmacokinetics: the influence of concomitant administration of cimetidineH Spahn, W Kirch, P Hajdu, et al.Arzneimittel-Forschung|November 1, 1986
Pharmacokinetics of salicylates administered with metoprololH Spahn, P Langguth, W Kirch, et al.Biopharmaceutics & Drug Disposition|January 1, 1983
Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprololW Kirch, H Spahn, E E Ohnhaus, et al.British Journal of Clinical Pharmacology|January 1, 1984
Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolismW Kirch, H Spahn, N R Kitteringham, et al.Arzneimittel-Forschung|January 1, 1981
[Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)]H Spahn, E MutschlerArzneimittel-Forschung|January 1, 1985
The influence of aluminium hydroxide on the bioavailability of feprazone. Single dose studyH Spahn, E MutschlerJournal of Chromatography|October 8, 1982
[Determination of feprazone and one of its metabolites in human plasma after high-performance liquid chromatographic or thin-layer chromatographic separation]H Spahn, E MutschlerPageof 62